CATALENT, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55 USD | -0.67% |
|
-1.43% | +22.41% |
| 05-16 | Argus Downgrades Catalent to Sell From Buy | MT |
| 05-14 | Novo Nordisk Selling $5 Billion in Bonds to Back Catalent Deal | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CATALENT, INC. | Other Pharmaceuticals | -0.67% | -1.43% | +22.41% | +47.97% | +21.23% | 10.02B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- CTLT Stock
- Charts Catalent, Inc.
- Comparison Chart